Brian Jones, MD
Pain Medicine · Kansas City, KSNPI 1346319316
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Nevro Corp. at 46.8% of the total. Reporting peaked in 2019 at $333 and has fallen 68.5% since, to $105 in 2025. That places this record below the midpoint for pain medicine clinicians in KS, where the typical reported total is $2,519.
Across 30 payments — averaging $26.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$371
- Tersera Therapeutics LLC$196
- Globus Medical$56
- Abbott$45
- Vertex$35
- Zyla Life Sciences, Inc.$26
- plus $62 from 5 others
What the payments were for
- Food & beverage$792100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 7 | $371 |
| Tersera Therapeutics LLC | 10 | $196 |
| Globus Medical | 2 | $56 |
| Abbott | 2 | $45 |
| Vertex | 2 | $35 |
| Zyla Life Sciences, Inc. | 2 | $26 |
| Medtronic | 1 | $14 |
| Spinal Simplicity, LLC | 1 | $14 |
| Shionogi Inc | 1 | $12 |
| Pfizer | 1 | $11 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnia$123
How this compares
$792 in reported general payments places this provider in the 40th percentile of 64 pain medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SavellaMilnacipran Hcl | 12 | $5,686 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 107 | $3,182 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 103 | $2,959 |
| Methadone Hcl | 46 | $2,378 |
| Fentanyl | 14 | $2,297 |
| Oxycodone Hcl | 59 | $1,214 |
| Gabapentin | 123 | $1,133 |
| Methylprednisolone | 148 | $1,128 |
| Cyclobenzaprine Hcl | 34 | $687 |
| Morphine Sulfate ErMorphine Sulfate | 27 | $593 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 17 | $536 |
| Celecoxib | 17 | $526 |
| Tizanidine Hcl | 44 | $313 |
| Diclofenac Sodium | 24 | $247 |
| Pregabalin | 17 | $234 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Kansas City
- Usman LatifKansas City$734K
- Dawood SayedKansas City$649K
- Andrea ChadwickKansas City$269K
- Christopher LamKansas City$31K
- Samuel PattonKansas City$30K
- Edward BraunKansas City$12K
- James KindscherKansas City$8K
- Sarafina KankamKansas City$3K
- Grace ShihKansas City$443
- Thomas SmithKansas City$164
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.